secwatch.observer — SEC 8-K summary
======================================

Issuer:     Covista Inc. (CVSA)
CIK:        0000730464
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001558370-24-013845
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adtalem Q1 FY2025: Revenue up 13.2%, adj. EPS $1.29 (+38.7% YoY); raises FY guidance
--------------------------------------------------------------------------------

- Revenue $417.4M (+13.2% YoY); net income $46.2M vs $10.6M prior year; adj. EPS $1.29 vs $0.93.
- Total enrollment 90,140, up 11.2% YoY; Chamberlain +11.7%, Walden +12.2%, Medical/Vet -0.7%.
- FY2025 guidance raised: revenue $1,690M-$1,730M; adj. EPS $5.75-$5.95 (14.5%-18.5% growth).
- Repurchased $34M of shares; $178M remaining under $300M buyback program through Jan 2027.
- Repriced $253M Term Loan B, reducing interest rate by 75 bps; net leverage 1.0x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730464/000155837024013845/0001558370-24-013845-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730464/000155837024013845/atge-20241029x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-013845

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer